Skip to content
DataLookout
Menu

NCT05718492

A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

StatusUnknown
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Jan 2023); last known: Recruiting
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Objective Response Rate (ORR)
Timeframe: 2-years Followed up
Progress Free Survival (PFS)
Timeframe: 2-years Followed up

Secondary (3)

Overall Survival (OS)
Tumor local control
Adverse Events (AEs)

Arms and interventions

HAICExperimental

Treated by HAIC alone.

Procedures: digital subtraction angiography.

Drugs: FOLFOX (oxaliplatin , leucovorin , fluorouracil , and fluorouracil )

Sites

1 site in 1 country

  • Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer CenterGuangzhou, Guangdong, China